Annual report
6063.TEDINET S100XUYQ
Period2025-01-01 → 2025-12-31
Filed2026-03-27
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 152
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.7bn | 2025-01-01 → 2025-12-31 | Cons. | Net sales |
| Revenue | ¥2.9bn | 2024-01-01 → 2024-12-31 | Cons. | Net sales |
| Revenue | ¥3.6bn | 2023-01-01 → 2023-12-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥6.2bn | 2022-01-01 → 2022-12-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.4bn | 2021-01-01 → 2021-12-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥96m | 2025-01-01 → 2025-12-31 | Cons. | Operating income |
| Operating income | ¥52m | 2024-01-01 → 2024-12-31 | Cons. | Operating income |
| Ordinary income | ¥104m | 2025-01-01 → 2025-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥64m | 2024-01-01 → 2024-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥181m | 2023-01-01 → 2023-12-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥730m | 2022-01-01 → 2022-12-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥244m | 2021-01-01 → 2021-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥121m | 2025-01-01 → 2025-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥63m | 2024-01-01 → 2024-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥102m | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥48m | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥120m | 2023-01-01 → 2023-12-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥500m | 2022-01-01 → 2022-12-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥179m | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥102m | 2025-01-01 → 2025-12-31 | Cons. | Profit loss |
| Net income | ¥48m | 2024-01-01 → 2024-12-31 | Cons. | Profit loss |
| Total assets | ¥3.8bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥3.8bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥3.7bn | at 2023-12-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥3.9bn | at 2022-12-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥3.8bn | at 2021-12-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.9bn | at 2025-12-31 | Cons. | Liabilities |
| Total liabilities | ¥2.0bn | at 2024-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.9bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥1.8bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥1.7bn | at 2023-12-31v | Cons. | Net assets |
| Net assets / equity | ¥1.6bn | at 2022-12-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥1.1bn | at 2021-12-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.5bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.3bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.3bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2023-12-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2022-12-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.7bn | at 2021-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥296m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥40m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥5m | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥920m | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥245m | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥86m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥112m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥43m | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥63m | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥17m | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥119m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥79m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥100m | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥310m | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥353m | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥40.44 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥19.06 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥47.63 | 2023-01-01 → 2023-12-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥198.5 | 2022-01-01 → 2022-12-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥71 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥198.42 | 2022-01-01 → 2022-12-31v | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥70.96 | 2021-01-01 → 2021-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥737.9 | at 2025-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥697.06 | at 2024-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥663.3 | at 2023-12-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥624.46 | at 2022-12-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥419.16 | at 2021-12-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 48.7% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.1% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.3% | at 2023-12-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.0% | at 2022-12-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 27.8% | at 2021-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 5.6% | 2025-01-01 → 2025-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 2.8% | 2024-01-01 → 2024-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.4% | 2023-01-01 → 2023-12-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 38.0% | 2022-01-01 → 2022-12-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 18.9% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 247 | at 2025-12-31 | Cons. | Number of employees |
| Employees | 229 | at 2024-12-31 | Cons. | Number of employees |
| Employees | 229 | at 2023-12-31v | Cons. | Number of employees |
| Employees | 234 | at 2022-12-31v | Cons. | Number of employees |
| Employees | 251 | at 2021-12-31d | Cons. | Number of employees |
| Revenue | ¥3.6bn | 2025-01-01 → 2025-12-31 | Standalone | Net sales |
| Revenue | ¥2.9bn | 2024-01-01 → 2024-12-31 | Standalone | Net sales |
| Revenue | ¥3.6bn | 2023-01-01 → 2023-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥6.2bn | 2022-01-01 → 2022-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥4.3bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥40m | 2025-01-01 → 2025-12-31 | Standalone | Operating income |
| Operating income | ¥15m | 2024-01-01 → 2024-12-31 | Standalone | Operating income |
| Ordinary income | ¥94m | 2025-01-01 → 2025-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥22m | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥153m | 2023-01-01 → 2023-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥700m | 2022-01-01 → 2022-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥219m | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥111m | 2025-01-01 → 2025-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥24m | 2024-01-01 → 2024-12-31 | Standalone | Income before income taxes |
| Net income | ¥95m | 2025-01-01 → 2025-12-31 | Standalone | Profit loss |
| Net income | ¥11m | 2024-01-01 → 2024-12-31 | Standalone | Profit loss |
| Net income | ¥99m | 2023-01-01 → 2023-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥477m | 2022-01-01 → 2022-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥154m | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥3.3bn | at 2025-12-31 | Standalone | Assets |
| Total assets | ¥3.3bn | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥3.3bn | at 2023-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.6bn | at 2022-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.5bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.9bn | at 2025-12-31 | Standalone | Liabilities |
| Total liabilities | ¥2.0bn | at 2024-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.4bn | at 2025-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2023-12-31v | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2022-12-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥803m | at 2021-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.0bn | at 2025-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.8bn | at 2024-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥37.69 | 2025-01-01 → 2025-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥4.47 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.15 | 2023-01-01 → 2023-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥189.49 | 2022-01-01 → 2022-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥61.31 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥189.42 | 2022-01-01 → 2022-12-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥61.27 | 2021-01-01 → 2021-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥9 | 2025-01-01 → 2025-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥8 | 2024-01-01 → 2024-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10 | 2023-01-01 → 2023-12-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥18 | 2022-01-01 → 2022-12-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10 | 2021-01-01 → 2021-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥533.61 | at 2025-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥503.93 | at 2024-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥504.46 | at 2023-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥488.31 | at 2022-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥308.82 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 40.8% | at 2025-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.1% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.8% | at 2023-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.1% | at 2022-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.1% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 7.3% | 2025-01-01 → 2025-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 0.9% | 2024-01-01 → 2024-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.9% | 2023-01-01 → 2023-12-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 47.5% | 2022-01-01 → 2022-12-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 22.0% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 2,519,600 | at 2025-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,519,600 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,519,600 | at 2023-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,519,600 | at 2022-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,519,600 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 169 | at 2025-12-31 | Standalone | Number of employees |
| Employees | 156 | at 2024-12-31 | Standalone | Number of employees |
| Employees | 164 | at 2023-12-31v | Standalone | Number of employees |
| Employees | 169 | at 2022-12-31v | Standalone | Number of employees |
| Employees | 179 | at 2021-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2025-01-01 → 2025-12-31 | ¥1m |
| Reconciling Itemsreconciling | depreciation | 2025-01-01 → 2025-12-31 | ¥2m |
| Reconciling Itemsreconciling | segment assets | at 2025-12-31 | ¥2.1bn |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-12-31 | −¥535m |
| Life Assitance Departmentreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥2m |
| Life Assitance Departmentreportable segment | depreciation | 2025-01-01 → 2025-12-31 | ¥11m |
| Life Assitance Departmentreportable segment | employees | at 2025-12-31 | 37 pure |
| Life Assitance Departmentreportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥484m |
| Life Assitance Departmentreportable segment | revenue external | 2025-01-01 → 2025-12-31 | ¥484m |
| Life Assitance Departmentreportable segment | segment assets | at 2025-12-31 | ¥14m |
| Life Assitance Departmentreportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥114m |
| Medical Assistance Departmentreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥33m |
| Medical Assistance Departmentreportable segment | depreciation | 2025-01-01 → 2025-12-31 | ¥32m |
| Medical Assistance Departmentreportable segment | employees | at 2025-12-31 | 186 pure |
| Medical Assistance Departmentreportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥3.2bn |
| Medical Assistance Departmentreportable segment | revenue external | 2025-01-01 → 2025-12-31 | ¥3.2bn |
| Medical Assistance Departmentreportable segment | segment assets | at 2025-12-31 | ¥1.7bn |
| Medical Assistance Departmentreportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥516m |
| —segment total | capex | 2025-01-01 → 2025-12-31 | ¥35m |
| —segment total | depreciation | 2025-01-01 → 2025-12-31 | ¥43m |
| —segment total | revenue | 2025-01-01 → 2025-12-31 | ¥3.7bn |
| —segment total | revenue external | 2025-01-01 → 2025-12-31 | ¥3.7bn |
| —segment total | segment assets | at 2025-12-31 | ¥1.7bn |
| —segment total | segment profit | 2025-01-01 → 2025-12-31 | ¥631m |
| Reconciling Itemsreconciling | depreciation | 2024-01-01 → 2024-12-31 | ¥3m |
| Reconciling Itemsreconciling | segment assets | at 2024-12-31 | ¥2.0bn |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-12-31 | −¥487m |
| Life Assitance Departmentreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥11m |
| Life Assitance Departmentreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥450m |
| Life Assitance Departmentreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥450m |
| Life Assitance Departmentreportable segment | segment assets | at 2024-12-31 | ¥19m |
| Life Assitance Departmentreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥101m |
| Medical Assistance Departmentreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥44m |
| Medical Assistance Departmentreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥33m |
| Medical Assistance Departmentreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥2.5bn |
| Medical Assistance Departmentreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥2.5bn |
| Medical Assistance Departmentreportable segment | segment assets | at 2024-12-31 | ¥1.8bn |
| Medical Assistance Departmentreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥439m |
| —segment total | capex | 2024-01-01 → 2024-12-31 | ¥44m |
| —segment total | depreciation | 2024-01-01 → 2024-12-31 | ¥44m |
| —segment total | revenue | 2024-01-01 → 2024-12-31 | ¥2.9bn |
| —segment total | revenue external | 2024-01-01 → 2024-12-31 | ¥2.9bn |
| —segment total | segment assets | at 2024-12-31 | ¥1.8bn |
| —segment total | segment profit | 2024-01-01 → 2024-12-31 | ¥540m |
| Life Assitance Departmentreportable segment | employees | at 2025-12-31 | 37 pure |
| Medical Assistance Departmentreportable segment | employees | at 2025-12-31 | 108 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,262
| Item | Context | Value | Unit |
|---|---|---|---|
| Transactions with other segments | CurrentYearDuration | － | JPY |
| Net sales | CurrentYearDuration_jpcrp030000-asr_E26625-000MedicalAssistanceDepartmentReportableSegmentsMember | 3230344000 | JPY |
| Net sales | CurrentYearDuration_jpcrp030000-asr_E26625-000LifeAssitanceDepartmentReportableSegmentsMember | 484330000 | JPY |
| Net sales | CurrentYearDuration_ReportableSegmentsMember | 3714674000 | JPY |
| Net sales | CurrentYearDuration_ReconcilingItemsMember | － | JPY |
| Net sales | CurrentYearDuration | 3714674000 | JPY |
| Operating income | CurrentYearDuration_jpcrp030000-asr_E26625-000MedicalAssistanceDepartmentReportableSegmentsMember | 516480000 | JPY |
| Operating income | CurrentYearDuration_jpcrp030000-asr_E26625-000LifeAssitanceDepartmentReportableSegmentsMember | 114396000 | JPY |
| Operating income | CurrentYearDuration_ReportableSegmentsMember | 630876000 | JPY |
| Operating income | CurrentYearDuration_ReconcilingItemsMember | -534765000 | JPY |
| Operating income | CurrentYearDuration | 96111000 | JPY |
| Assets | CurrentYearInstant_jpcrp030000-asr_E26625-000MedicalAssistanceDepartmentReportableSegmentsMember | 1686014000 | JPY |
| Assets | CurrentYearInstant_jpcrp030000-asr_E26625-000LifeAssitanceDepartmentReportableSegmentsMember | 13982000 | JPY |
| Assets | CurrentYearInstant_ReportableSegmentsMember | 1699997000 | JPY |
| Assets | CurrentYearInstant_ReconcilingItemsMember | 2113960000 | JPY |
| Assets | CurrentYearInstant | 3813957000 | JPY |
| Depreciation segment information | CurrentYearDuration_jpcrp030000-asr_E26625-000MedicalAssistanceDepartmentReportableSegmentsMember | 31815000 | JPY |
| Depreciation segment information | CurrentYearDuration_jpcrp030000-asr_E26625-000LifeAssitanceDepartmentReportableSegmentsMember | 10831000 | JPY |
| Depreciation segment information | CurrentYearDuration_ReportableSegmentsMember | 42647000 | JPY |
| Depreciation segment information | CurrentYearDuration_ReconcilingItemsMember | 2195000 | JPY |
| Depreciation segment information | CurrentYearDuration | 44842000 | JPY |
| Increase in property plant and equipment and intangible assets | CurrentYearDuration_jpcrp030000-asr_E26625-000MedicalAssistanceDepartmentReportableSegmentsMember | 33432000 | JPY |
| Increase in property plant and equipment and intangible assets | CurrentYearDuration_jpcrp030000-asr_E26625-000LifeAssitanceDepartmentReportableSegmentsMember | 2036000 | JPY |
| Increase in property plant and equipment and intangible assets | CurrentYearDuration_ReportableSegmentsMember | 35468000 | JPY |
| Increase in property plant and equipment and intangible assets | CurrentYearDuration_ReconcilingItemsMember | 1435000 | JPY |
| Increase in property plant and equipment and intangible assets | CurrentYearDuration | 36904000 | JPY |
| Cash and deposits | Prior1YearInstant_NonConsolidatedMember | 1817784000 | JPY |
| Cash and deposits | CurrentYearInstant_NonConsolidatedMember | 1953559000 | JPY |
| Accounts receivable trade and contract assets | Prior1YearInstant_NonConsolidatedMember | 193158000 | JPY |
| Accounts receivable trade and contract assets | CurrentYearInstant_NonConsolidatedMember | 233490000 | JPY |
| Work in process | Prior1YearInstant_NonConsolidatedMember | 105259000 | JPY |
| Work in process | CurrentYearInstant_NonConsolidatedMember | － | JPY |
| Advances paid | Prior1YearInstant_NonConsolidatedMember | 730494000 | JPY |
| Advances paid | CurrentYearInstant_NonConsolidatedMember | 674398000 | JPY |
| Advance payments trade | Prior1YearInstant_NonConsolidatedMember | 873000 | JPY |
| Advance payments trade | CurrentYearInstant_NonConsolidatedMember | 572000 | JPY |
| Prepaid expenses | Prior1YearInstant_NonConsolidatedMember | 80019000 | JPY |
| Prepaid expenses | CurrentYearInstant_NonConsolidatedMember | 91622000 | JPY |
| Other ca | Prior1YearInstant_NonConsolidatedMember | 127118000 | JPY |
| Other ca | CurrentYearInstant_NonConsolidatedMember | 65616000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant_NonConsolidatedMember | -4053000 | JPY |
| Allowance for doubtful accounts ca | CurrentYearInstant_NonConsolidatedMember | -5715000 | JPY |
| Current assets | Prior1YearInstant_NonConsolidatedMember | 3050654000 | JPY |
| Current assets | CurrentYearInstant_NonConsolidatedMember | 3013545000 | JPY |
| Buildings net | Prior1YearInstant_NonConsolidatedMember | 20294000 | JPY |
| Buildings net | CurrentYearInstant_NonConsolidatedMember | 20519000 | JPY |
| Furniture and fixtures net | Prior1YearInstant_NonConsolidatedMember | 21218000 | JPY |
| Furniture and fixtures net | CurrentYearInstant_NonConsolidatedMember | 16180000 | JPY |
| Property plant and equipment | Prior1YearInstant_NonConsolidatedMember | 41513000 | JPY |
| Property plant and equipment | CurrentYearInstant_NonConsolidatedMember | 36699000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |